Literature DB >> 34207985

The Role of Extracellular Vesicles as Shuttles of RNA and Their Clinical Significance as Biomarkers in Hepatocellular Carcinoma.

Eva Costanzi1, Carolina Simioni2,3, Gabriele Varano1,3, Cinzia Brenna1,3, Ilaria Conti1, Luca Maria Neri1,3.   

Abstract

Extracellular vesicles (EVs) have attracted interest as mediators of intercellular communication following the discovery that EVs contain RNA molecules, including non-coding RNA (ncRNA). Growing evidence for the enrichment of peculiar RNA species in specific EV subtypes has been demonstrated. ncRNAs, transferred from donor cells to recipient cells, confer to EVs the feature to regulate the expression of genes involved in differentiation, proliferation, apoptosis, and other biological processes. These multiple actions require accuracy in the isolation of RNA content from EVs and the methodologies used play a relevant role. In liver, EVs play a crucial role in regulating cell-cell communications and several pathophysiological events in the heterogeneous liver class of cells via horizontal transfer of their cargo. This review aims to discuss the rising role of EVs and their ncRNAs content in regulating specific aspects of hepatocellular carcinoma development, including tumorigenesis, angiogenesis, and tumor metastasis. We analyze the progress in EV-ncRNAs' potential clinical applications as important diagnostic and prognostic biomarkers for liver conditions.

Entities:  

Keywords:  RNA; biomarker; extracellular vesicles; hepatocellular carcinoma; liquid biopsy; non-coding RNA

Year:  2021        PMID: 34207985     DOI: 10.3390/genes12060902

Source DB:  PubMed          Journal:  Genes (Basel)        ISSN: 2073-4425            Impact factor:   4.096


  2 in total

1.  Critical biomarkers of hepatocellular carcinoma in body fluids and gut microbiota.

Authors:  Lekshmi R Nath; Maneesha Murali; Bhagyalakshmi Nair
Journal:  World J Gastrointest Oncol       Date:  2021-12-15

2.  Extracellular Vesicle-Encapsulated MicroRNA-375 from Bone Marrow-Derived Mesenchymal Stem Cells Inhibits Hepatocellular Carcinoma Progression through Regulating HOXB3-Mediated Wnt/β-Catenin Pathway.

Authors:  Zhaoxia Yu; Ju Liu; Qiqi Fan; Jun Yu; Xiaoting Ren; Xiaobin Wang
Journal:  Anal Cell Pathol (Amst)       Date:  2022-01-27       Impact factor: 2.916

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.